MedPath

Oxytocin Effects on the Tolerance of Infidelity

Not Applicable
Completed
Conditions
Healthy
Interventions
Drug: placebo treatment
Registration Number
NCT02733237
Lead Sponsor
University of Electronic Science and Technology of China
Brief Summary

To investigate whether intranasal oxytocin (40 IU) treatment can influence the tolerance of infidelity in males and females.

Detailed Description

In a double-blind, between-subject, placebo controlled design, investigators plan to investigate the effect of oxytocin treatment on the tolerance of infidelity. Male and female subjects would firstly see a neutral face of the opposite sex presented with a sentence descried their fidelity or infidelity behavior (sexual or emotional) in a relationship. Next the participant will rate the attractiveness, likability and trustworthiness of each individual, and whether they would like to have a short/long relationship with him/her. After that there will be some implicit attitude tasks to test their implicit attitude towards potential partners exhibiting previous fidelity or and infidelity.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
160
Inclusion Criteria
  • Healthy subjects without past or current psychiatric or neurological disorders
Exclusion Criteria
  • history of head injury;
  • pregnant,menstruating,taking oral contraceptives
  • medical or psychiatric illness.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
male oxytocin groupoxytocin treatmentmale subjects with oxytocin treatment
male placebo groupplacebo treatmentmale subjects with placebo treatment
female oxytocin groupoxytocin treatmentfemale subjects with oxytocin treatment
female placebo groupplacebo treatmentfemale subjects with placebo treatment
Primary Outcome Measures
NameTimeMethod
attitude towards fidelity and infidelity of potential mate.1 hour

attitude is measured by the rating scores for likability, attractiveness and trustworthiness

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

China, Sichuan

🇨🇳

Chengdu, Sichuan, China

© Copyright 2025. All Rights Reserved by MedPath